Phibro Animal Health (PAHC) to Release Quarterly Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) is expected to be announcing its Q3 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $352.41 million for the quarter. Phibro Animal Health has set its FY 2025 guidance at 1.870-2.010 EPS.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Phibro Animal Health Stock Up 0.0 %

NASDAQ:PAHC traded up $0.01 during trading hours on Monday, reaching $19.49. 91,859 shares of the company traded hands, compared to its average volume of 189,133. Phibro Animal Health has a 1 year low of $16.06 and a 1 year high of $26.55. The stock has a market capitalization of $789.36 million, a P/E ratio of 40.63, a P/E/G ratio of 0.45 and a beta of 0.62. The business's 50-day moving average price is $20.26 and its two-hundred day moving average price is $21.95. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.46%. The ex-dividend date of this dividend was Wednesday, March 5th. Phibro Animal Health's payout ratio is 100.00%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on PAHC shares. StockNews.com cut shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Morgan Stanley set a $20.00 target price on Phibro Animal Health in a research note on Tuesday, April 15th. Finally, Barclays lifted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a report on Monday, February 10th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $19.75.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.